| 1 |
[GO] |
2025―Mrz―21 |
Human-genetic variants associated with susceptibility to SARS-CoV-2 infection |
Daniel Azcarate, Felix Olasagasti Arsuaga, Eva Granizo Rodriguez, Eunate Arana-Arri, Pedro Pablo España, Maider Intxausti, Cristina Sancho, Aitor García de Vicuña Meléndez, Oliver Ibarrondo, Marian M. de Pancorbo |
| 2 |
[GO] |
2025―Mrz―12 |
Evaluation of hypoxia pathway genes and serum parameters in new coronavirus pneumonia (COVID-19) |
Mesut Oterkus, Mukaddes Pala, Senay Gorucu Yilmaz, Elif Seren Tanriverdi, Ayten Gunduz, Leman Acun Delen, Dilara Altay Ozturk, Cihan Döger |
| 3 |
[GO] |
2025―Feb―27 |
Computational and Mathematical Genomics of Coronaviruses |
Sk.Sarif Hassan, Debaleena Nawn, Vladimir N. Uversky |
| 4 |
[GO] |
2024―Nov―15 |
Characterization of novel ACE2 mRNA transcripts: The potential role of alternative splicing in SARS-CoV-2 infection |
Panagiotis G. Adamopoulos, Natalia Bartzoka, Panagiotis Tsiakanikas, Andreas Scorilas |
| 5 |
[GO] |
2024―Okt―23 |
Optimal control analysis on the spread of COVID-19: Impact of contact transmission and environmental contamination |
Sunil Singh Negi, Nitin Sharma, Anupam Priyadarshi |
| 6 |
[GO] |
2024―Okt―20 |
Insights into disease resilience and longevity: Hints from COVID-19 recovered nonagenarians and centenarians |
Mateus V. de Castro, Cristina Sábato, Raíssa M. Dandalo-Girardi, Monize V.R. Silva, Luiz P. Dell’Aquila, Álvaro Razuk-Filho, Pedro B. Batista-Júnior, Michel S. Naslavsky, Mayana Zatz |
| 7 |
[GO] |
2024―Sep―30 |
Mathematical model for understanding the relationship between diabetes and novel coronavirus |
Preety Kumari, Harendra Pal Singh, Swarn Singh |
| 8 |
[GO] |
2024―Aug―06 |
Modelling on COVID-19 control with double and booster-dose vaccination |
Preety Kalra, Shoket Ali, Samuel Ocen |
| 9 |
[GO] |
2024―Mai―31 |
Based on epidemiological parameter data, probe into a stochastically perturbed dominant variant of the COVID-19 pandemic model |
S.P. Rajasekar, R. Ramesh, Yassine Sabbar |
| 10 |
[GO] |
2024―Mai―22 |
Dual-strain dynamics of COVID-19 variants in India: Modeling, analysis, and implications for pandemic control |
Sunil Singh Negi, Nitin Sharma, Haci Mehmet Baskonus |
| 11 |
[GO] |
2024―Mai―16 |
Delving a stochastic SEQAIJR COVID-19 model with hexa delayed and copious control strategies |
M. Pitchaimani, U. Aswini |
| 12 |
[GO] |
2024―Mai―14 |
An entropy-based study on the mutational landscape of SARS-CoV-2 in USA: comparing different variants and revealing co-mutational behavior of proteins |
Daniele Santoni |
| 13 |
[GO] |
2024―Mai―13 |
Long-term effect of SARS-CoV-2 variant : Challenging issues and controlling strategies |
M. Pitchaimani, U. Aswini |
| 14 |
[GO] |
2024―Mai―10 |
Repurposing of antimycobacterium drugs for COVID-19 treatment by targeting SARS CoV-2 main protease: An in-silico perspective |
Ayon Chakraborty, Rajesh Ghosh, Saswati Soumya Mohapatra, Subhashree Barik, Ashis Biswas, Snehasis Chowdhuri |
| 15 |
[GO] |
2024―Apr―24 |
Whole genome analysis reveals unique traits of SARS-CoV-2 in pediatric patients |
Sara Chandy, Hithesh Kumar, Sara Pearl, Soumya Basu, Gurumoorthy M, Janani Sankar, Anand Manoharan, Sudha Ramaiah, Anand Anbarasu |
| 16 |
[GO] |
2024―Apr―03 |
Dynamic analysis of SARS-CoV-2 evolution based on different countries |
Binghan Xiao, Linhuan Wu, Qinlan Sun, Chang Shu, Songnian Hu |
| 17 |
[GO] |
2024―Apr―02 |
A positive selection at binding site 501 in the B.1 lineage might have triggered the highly infectious sub-lineages of SARS-CoV-2 |
Basant K. Tiwary |
| 18 |
[GO] |
2024―Mrz―14 |
SARS-CoV-2 and UPS with potentials for therapeutic interventions |
Jannatul Ferdoush, Rizwaan Abdul Kadir, Selin Simay Kaplanoglu, Morgan Osborn |
| 19 |
[GO] |
2024―Mrz―12 |
Nigella sativa, Anthemis hyaline and Citrus sinensis extracts reduce SARS-CoV-2 replication by fluctuating Rho GTPase, PI3K-AKT, and MAPK/ERK pathways in HeLa-CEACAM1a cells |
Mehmet Bostancıklıoğlu, Mehri İğci, Mustafa Ulaşlı |
| 20 |
[GO] |
2024―Mrz―07 |
Chaos theory in the understanding of COVID-19 pandemic dynamics |
Arianna Calistri, Pier Francesco Roggero, Giorgio Palé |
| 21 |
[GO] |
2024―Feb―28 |
Geometric analysis of SARS-CoV-2 variants |
Mengcen Guan, Nan Sun, Stephen S.-T. Yau |
| 22 |
[GO] |
2024―Feb―03 |
Single-Nucleotide Polymorphisms Related to Vitamin D Metabolism and Severity or Mortality of COVID-19: A Systematic Review and Meta-analysis |
Carla Regina da Silva Correa da Ronda, Marília Berlofa Visacri, Júlia Tiemi Siguemoto, Carolini Motta Neri, Micaela Crispim Lopo de Abreu, Aline de Souza Nicoletti, Inajara Rotta, Carolina Dagli-Hernandez, Pedro Moriel Pincinato, Eder de Carvalho Pincinato, Patricia Moriel |
| 23 |
[GO] |
2023―Sep―01 |
Bioinformatics analysis of carotid vulnerable plaques associated with the SARS-CoV-2 pattern |
Tao Jiang, Jiaming Huang, Shupeng Li, Qiushi Xu, Tianding Zhang, Xianwei Wang, Dong Chen |
| 24 |
[GO] |
2023―Jul―08 |
Targeting cytokine storm as the potential anti-viral therapy: Implications in regulating SARS-CoV-2 pathogenicity |
Subashish Maity, Ayantika Santra, Ananda Vardhan Hebbani, Swetha Pulakuntla, Ankita Chatterjee, Kameswara Rao Badri, Vaddi Damodara Reddy |
| 25 |
[GO] |
2023―Mrz―02 |
INFLAMMASOME GENES POLYMORPHISMS ARE ASSOCIATED WITH PROGRESSION TO MECHANICAL VENTILATION AND DEATH IN A COHORT OF HOSPITALIZED COVID-19 PATIENTS IN A REFERENCE HOSPITAL IN RIO DE JANEIRO, BRAZIL |
Milena Neira-Goulart, Nathalia Beatriz Ramos de Sá, Marcelo Ribeiro-Alves, Hugo Perazzo, Kim Mattos Geraldo, Maria Pia Diniz Ribeiro, Sandra Wagner Cardoso, Beatriz Grinsztejn, Valdiléa G. Veloso, Larissa Rodrigues Gomes, Andressa da Silva Cazote, Dalziza Victalina de Almeida, Carmem Beatriz Wagner Giacoia-Gripp, Fernanda Heloise Côrtes, Mariza Gonçalves Morgado |
| 26 |
[GO] |
2023―Feb―02 |
Emerging role of microRNAs and long non-coding RNAs in COVID-19 with implications to therapeutics |
Kaifee Arman, Zeinab Dalloul, Esra Bozgeyik |
| 27 |
[GO] |
2022―Dez―25 |
Loss of furin site enhances SARS-CoV-2 spike protein pseudovirus infection |
Zeng Wang, Kunhong Zhong, Guoqing Wang, Qizhong Lu, Hexian Li, Zhiguo Wu, Zongliang Zhang, Nian Yang, Meijun Zheng, Yuelong Wang, Chunlai Nie, Liangxue Zhou, Aiping Tong |
| 28 |
[GO] |
2022―Dez―05 |
In silico analysis of genomic landscape of SARS-CoV-2 and its variant of concerns (Delta and Omicron) reveals changes in the coding potential of miRNAs and their target genes |
Sandeep Saini, Savi Khurana, Dikshant Saini, Saru Rajput, Chander Jyoti Thakur, Jeevisha Singh, Akanksha Jaswal, Yogesh Kapoor, Varinder Kumar, Avneet Saini |
| 29 |
[GO] |
2022―Nov―13 |
Transcriptional profiles and common genes link lung cancer with the development and severity of COVID-19 |
SS. Cury, JS. Oliveira, CAO. Biagi-Júnior, Silva Jr WA, PP. Reis, O. Cabral-Marques, EN. Hasimoto, PP. Freire, RF. Carvalho |
| 30 |
[GO] |
2022―Nov―04 |
Geographical distribution of host's specific SARS-CoV-2 mutations in the early phase of the COVID-19 pandemic |
Mohammad Khalid, David Murphy, Maryam Shoai, Jonahunnatha Nesson George-William, Yousef Al-ebini |
| 31 |
[GO] |
2022―Aug―17 |
Systematic review and meta-analysis of human genetic variants contributing to COVID-19 susceptibility and severity |
Kajal Gupta, Gaganpreet Kaur, Tejal Pathak, Indranil Banerjee |
| 32 |
[GO] |
2022―Jul―27 |
Analysis of the mutation dynamics of sars-cov-2 genome in the samples from georgia state of the united states |
Waqas Ahmad, Sarfraz Ahmad, Riyaz Basha |
| 33 |
[GO] |
2022―Jun―28 |
Functional associations between polymorphic regions of the human 3′IgH locus and COVID-19 disease |
Mattia Colucci, Domenico Frezza, Giovanni Gambassi, Francesco De Vito, Angela Iaquinta, Maria Grazia Massaro, Simona Di Giambenedetto, Alberto Borghetti, Francesca Lombardi, Noemi Panzironi, Valentino Ruggieri, Vincenzo Giambra, Rossella Cianci |
| 34 |
[GO] |
2022―Jun―18 |
Roles of Mitochondrial DNA in Dynamics of the Immune Response to COVID-19 |
Ata Mahmoodpoor, Sarvin Sanaie, Zoherh Ostadi, Maqsoud Eskandari, Nazila Behrouzi, Roqayyeh Asghari, Ahmad Zahirnia, Nasim Sohrabifar, Somayeh Kazeminasab |
| 35 |
[GO] |
2022―Jun―14 |
The Association of COVID-19 Severity and Susceptibility and Genetic Risk Factors: A Systematic Review of the literature |
Angela Ishak, Meghana Mehendale, Mousa Mahmoud AlRawashdeh, Cristina Sestacovschi, Medha Sharath, Krunal Pandav, Sima Marzban |
| 36 |
[GO] |
2022―Jun―11 |
Variation in synonymous nucleotide composition among genomes of sarbecoviruses and consequences for the origin of COVID-19 |
Alexandre Hassanin |
| 37 |
[GO] |
2022―Jun―06 |
Immunoregulation of Ghrelin in neurocognitive sequelae associated with COVID-19: an in silico investigation |
Cristina Russo, Giovanna Morello, Giuliana Mannino, Antonella Russo, Lucia Malaguarnera |
| 38 |
[GO] |
2022―Mai―13 |
Human T-lymphotropic virus type 1 and novel Coronavirus Disease 2019; More complex than just a simple coinfection |
Samaneh Sajjadi, Sepideh Hejazi, Sahar Ravanshad, Reza Jafarzadeh Esfehani |
| 39 |
[GO] |
2022―Mrz―22 |
Mind the feline coronavirus: Comparison with SARS-CoV-2 |
Yong-yu Gao, Xiang-yu Liang, Qian Wang, Shuang Zhang, Han Zhao, Kai Wang, Gui-xue Hu, William J. Liu, Feng-shan Gao |
| 40 |
[GO] |
2022―Mrz―04 |
Role of Genomics in combating COVID-19 pandemic |
K.A. Saravanan, Manjit Panigrahi, Harshit Kumar, Divya Rajawat, Sonali Sonejita Nayak, Bharat Bhushan, Triveni Dutt |
| 41 |
[GO] |
2022―Jan―06 |
Palindromic Target Site Identification in SARS-CoV-2, MERS-CoV and SARS-CoV-1 by Adopting CRISPR-Cas Technique |
Nimisha Ghosh, Indrajit Saha, Nikhil Sharma |
| 42 |
[GO] |
2022―Jan―04 |
From Delta to Omicron: S1-RBD/S2 mutation/deletion equilibrium in SARS-CoV-2 defined variants |
Vasileios Papanikolaou, Aris Chrysovergis, Vasileios Ragos, Evangelos Tsiambas, Spyros Katsinis, Arezina Manoli, Sotirios Papouliakos, Dimitrios Roukas, Stylianos Mastronikolis, Dimitrios Peschos, Anna Batistatou, Efthimios Kyrodimos, Nicholas Mastronikolis |
| 43 |
[GO] |
2021―Nov―27 |
Understanding the role of telomere attrition and epigenetic signatures in COVID-19 severity |
Ata Mahmoodpoor, Sarvin Sanaie, Faranak Roudbari, Tara Sabzevari, Nasim Sohrabifar, Somayeh Kazeminasab |
| 44 |
[GO] |
2021―Sep―14 |
An overview of human proteins and genes involved in SARS-CoV-2 infection |
Zohreh Jahanafrooz, Zhishan Chen, Jiandong Bao, Hongzhi Li, Loren Lipworth, Xingyi Guo |
| 45 |
[GO] |
2021―Jul―16 |
Therapeutic perceptions in antisense RNA-mediated gene regulation for COVID-19 |
Sabrina Ferreira de Jesus, Laércio Ives Santos, João Felício Rodrigues Neto, Thallyta Maria Vieira, João Batista Mendes, Marcos Flavio Silveira Vasconcelos D'angelo, André Luiz Sena Guimaraes |
| 46 |
[GO] |
2021―Jul―16 |
No association between the SARS-CoV-2 variants and mortality rates in the Eastern Mediterranean Region |
Saad Omais, Samer Kharroubi, Hassan Zaraket |
| 47 |
[GO] |
2021―Jun―24 |
Variants in AGTR2 gene in Maya people with COVID-19 |
Armando Totomoch-Serra, Miriam Givisay Domínguez-Cruz, C. Manterola, María de Lourdes Muñoz |
| 48 |
[GO] |
2021―Apr―20 |
Inferring molecular mechanisms of dexamethasone therapy in severe COVID-19 from existing transcriptomic data |
Abhay Sharma |
| 49 |
[GO] |
2021―Mrz―23 |
SARS-CoV-2 variants lacking ORF8 occurred in farmed mink and pangolin |
Filipe Pereira |
| 50 |
[GO] |
2021―Mrz―18 |
Epidemiological transcriptomic data supports BCG protection in viral diseases including COVID-19 |
Abhay Sharma |
| 51 |
[GO] |
2021―Feb―15 |
Transmission dynamics of SARS-CoV-2 on the Diamond Princess uncovered using viral genome sequence analysis |
Kunikazu Hoshino, Tatsuji Maeshiro, Nao Nishida, Masaya Sugiyama, Jiro Fujita, Takashi Gojobori, Masashi Mizokami |
| 52 |
[GO] |
2021―Feb―11 |
Low serum CCL17 as a marker for severe/critical COVID-19: a pathogenic link |
Abhay Sharma |
| 53 |
[GO] |
2021―Feb―05 |
The use of mesenchymal stem cells in the process of treatment and tissue regeneration after recovery in patients with Covid-19 |
Ehsan Saburi, Mohamadfoad Abazari, Hadi Hasannia, Reyhaneh Nassiri mansour, Reza Eshaghi-Gorji, Mobina Gheibi, Mohamad Rahmati, Seyed Ehsan Enderami |
| 54 |
[GO] |
2021―Feb―05 |
Mutational analysis and assessment of its impact on proteins of SARS-CoV-2 genomes from India |
Rezwanuzzaman Laskar, Safdar Ali |
| 55 |
[GO] |
2020―Dez―17 |
Recognition of Plausible Therapeutic Agents to Combat COVID-19: An Omics Data Based Combined Approach |
Mohammad Uzzal Hossain, Arittra Bhattacharjee, Md. Tabassum Hossain Emon, Zeshan Mahmud Chowdhury, Md. Golam Mosaib, Muntahi Mourin, Keshob Chandra Das, Chaman Ara Keya, Md. Salimullah |
| 56 |
[GO] |
2020―Nov―28 |
The potential involvement of JAK-STAT signaling pathway in the COVID-19 infection assisted by ACE2 |
Jing Luo, Saisai Lu, Mengjiao Yu, Lixia Zhu, Chengwei Zhu, Chenlu Li, Jinxia Fang, Xiaochun Zhu, Xiaobing Wang |
| 57 |
[GO] |
2020―Nov―18 |
Essential functional molecules associated with SARS-CoV-2 infection: Potential therapeutic targets for COVID-19 |
Keshav Rajarshi, Rajni Khan, Mrityunjay K Singh, Tushar Ranjan, Sandipan Ray, Shashikant Ray |
| 58 |
[GO] |
2020―Sep―14 |
Serum CCL17 level becomes a predictive marker to distinguish between mild/moderate and severe/critical disease in patients with COVID-19 |
Masaya Sugiyama, Noriko Kinoshita, Satoshi Ide, Hidetoshi Nomoto, Takato Nakamoto, Sho Saito, Masahiro Ishikane, Satoshi Kutsuna, Kayoko Hayakawa, Masao Hashimoto, Manabu Suzuki, Shinyu Izumi, Masayuki Hojo, Kiyoto Tsuchiya, Hiroyuki Gatanaga, Jin Takasaki, Masahide Usami, Toshikazu Kano, Hidekatsu Yanai, Nao Nishida, Tatsuya Kanto, Haruhito Sugiyama, Norio Ohmagari, Masashi Mizokami |
| 59 |
[GO] |
2020―Aug―31 |
Angiotensin-converting enzymes (ACE, ACE2) gene variants and COVID-19 outcome |
Juan Gómez, Guillermo M Albaiceta, Marta García-Clemente, Carlos López-Larrea, Laura Amado-Rodríguez, Inés Lopez-Alonso, Tamara Hermida, Ana I. Enriquez, Pablo Herrero, Santiago Melón, Marta E. Alvarez-Argüelles, José A. Boga, Susana Rojo-Alba, Elías Cuesta-Llavona, Victoria Alvarez, Rebeca Lorca, Eliecer Coto |
| 60 |
[GO] |
2020―Aug―15 |
Unravelling host-pathogen interactions: ceRNA network in SARS-CoV-2 infection (COVID-19) |
Shweta Arora, Prithvi Singh, Ravins Dohare, Rishabh Jha, Mansoor Ali Syed |
| 61 |
[GO] |
2020―Jul―04 |
SARS-CoV-2 infections and COVID-19 mortalities strongly correlate with ACE1 I/D genotype |
Naoki Yamamoto, Yasuo Ariumi, Nao Nishida, Rain Yamamoto, Georg Bauer, Takashi Gojobori, Kunitada Shimotohno, Masashi Mizokami |
| 62 |
[GO] |
2020―Mai―20 |
Overwhelming Mutations or SNPs of SARS-CoV-2: A Point of Caution |
Naveen Vankadari |
